Home > DARE Reviews > Sodium-glucose cotransporter 2...
  • We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews.

Sodium-glucose cotransporter 2 inhibitors for Type 2 diabetes: a systematic review and meta-analysis

Review published: 2013.

Bibliographic details: Vasilakou D, Karagiannis T, Athanasiadou E, Mainou M, Liakos A, Bekiari E, Sarigianni M, Matthews DR, Tsapas A.  Sodium-glucose cotransporter 2 inhibitors for Type 2 diabetes: a systematic review and meta-analysis. Annals of Internal Medicine 2013; 159(4): 262-274. [PubMed: 24026259]

Quality assessment

This well-conducted review concluded that sodium-glucose cotransporter 2 inhibitors may improve some short-term outcomes in adults with type 2 diabetes, but the effects on long-term outcomes and safety were unclear. These cautious conclusions reflect the limitations of the evidence identified and are likely to be reliable. Full critical summary

CRD has determined that this article meets the DARE scientific quality criteria for a systematic review.

Copyright © 2013 University of York.

PubMed Health Blog...

read all...